Amanote Research
Register
Sign In
The Early Growth Response Protein 1-miR-30a-5p-Neurogenic Differentiation Factor 1 Axis as a Novel Biomarker for Schizophrenia Diagnosis and Treatment Monitoring
Translational Psychiatry
- United Kingdom
doi 10.1038/tp.2016.268
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Molecular Neuroscience
Biological Psychiatry
Mental Health
Cellular
Date
January 1, 2017
Authors
S Liu
F Zhang
Y Y Shugart
L Yang
X Li
Z Liu
N Sun
C Yang
X Guo
J Shi
L Wang
L Cheng
K Zhang
T Yang
Y Xu
Publisher
Springer Science and Business Media LLC
Related search
Combined Detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for Screening of Early Heart Failure Diseases
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer
Journal of Oncology
Oncology
Early Growth Response Protein 1 (EGR1)
Science-Business eXchange
Response to “Comment on ‘Insulin-Like Growth Factor 1 – A Novel Biomarker of Abdominal Aortic Aneurysm’”
European Journal of Vascular and Endovascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
The Progress of Early Growth Response Factor 1 and Leukemia
Intractable and Rare Diseases Research
Medicine
MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7
PLoS ONE
Multidisciplinary
Exosomal miR-665 as a Novel Minimally Invasive Biomarker for Hepatocellular Carcinoma Diagnosis and Prognosis
Oncotarget
Oncology
miR-140-5p Regulates Adipocyte Differentiation by Targeting Transforming Growth Factor-Β Signaling
Scientific Reports
Multidisciplinary
Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity Among Patients With FSGS
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
